Richard Timms | |
Country: | England |
Fullname: | Richard Thomas Timms |
Birth Date: | 23 August 1986 |
Birth Place: | Bristol, England |
Batting: | Right-handed |
Club1: | Somerset Cricket Board |
Year1: | 2002 |
Club2: | Cambridge University |
Year2: | 2005 - 2008 |
Columns: | 2 |
Column1: | First-class |
Matches1: | 7 |
Runs1: | 242 |
Bat Avg1: | 18.61 |
100S/50S1: | 0/2 |
Top Score1: | 57 |
Deliveries1: | 96 |
Wickets1: | 0 |
Bowl Avg1: | - |
Fivefor1: | 0 |
Tenfor1: | 0 |
Best Bowling1: | 0/75 |
Catches/Stumpings1: | 2/ - |
Column2: | List A |
Matches2: | 1 |
Runs2: | 38 |
Bat Avg2: | - |
100S/50S2: | 0/0 |
Top Score2: | 38 |
Deliveries2: | 0 |
Wickets2: | - |
Bowl Avg2: | - |
Fivefor2: | - |
Tenfor2: | n/a |
Best Bowling2: | - |
Catches/Stumpings2: | 0/ - |
Date: | 5 May |
Year: | 2010 |
Source: | https://cricketarchive.com/Archive/Players/45/45434/45434.html CricketArchive |
Richard Thomas Timms (born 23 August 1986 in Bristol) is an English geneticist and molecular biologist and former cricketer.
Richard Timms is married and lives with his wife in Cambridge, UK.
Richard is a right-handed batsman and fast-medium bowler. He attended Millfield School, and was captain of the first XI while there. He made his List A debut in 2002 for Somerset Cricket Board, playing in the first round of the Cheltenham and Gloucester Trophy. He scored 38 not out, batting at number eight.[1] He played Second XI cricket for Somerset from 2004 until 2006, but failed to break into the first-team. While at Cambridge University, he played seven first-class matches for the university, including two Varsity matches. He scored two half-centuries in first-class cricket, against Warwickshire,[2] and Oxford University.[3]
Richard Timms completed his PhD in at the Cambridge Institute for Medical Research in Cambridge, England where he performed genetic screens to identify functions of genes. In particular, he identified the HUSH complex as a regulator of epigenetic repression. After graduating, he continued in the laboratory of Stephen Elledge at Harvard Medical School, where he characterized N-end and C-end protein degradation pathways. He started his own laboratory at the University of Cambridge in 2020.